Physician

Vijay Paudel, MD

According to 2025 Medicare claims, Vijay Paudel, MD (NPI: 1972596484) practices hematology/oncology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is COASTAL CANCER CENTER LLC (NPI: 1881614170; TIN: 570777346) and primary practice location at 29572-4128.

Paudel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,228 traditional Medicare patients, billed 247,318 HCPCS/CPT codes, and received $3,428,870 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 499 prescription claims across 105 beneficiaries totaling $1,504,462 in drug costs, led by Inlyta (Axitinib). DME data shows 38 claims. Open Payments data shows 13 records totaling $305. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $4,978,698 to $3,428,870. In contrast, Part D prescription costs have risen steadily, from $773,791 to $1,504,462. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,657	678,002	$4,978,698
2016	1,567	596,556	$4,655,384
2017	1,503	711,375	$5,054,154
2018	1,354	496,382	$4,238,327
2019	1,516	617,703	$4,162,112
2020	1,513	488,360	$4,442,381
2021	950	291,174	$3,032,987
2022	1,004	212,713	$3,068,501
2023	827	176,108	$2,802,010
2024	1,228	247,318	$3,428,870

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	227	991	$773,791
2016	178	669	$493,465
2017	178	714	$606,985
2018	137	650	$863,013
2019	121	455	$1,214,852
2020	118	442	$1,049,108
2021	106	432	$995,772
2022	101	461	$1,052,315
2023	101	454	$1,123,221
2024	105	499	$1,504,462

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	55	290	$11,515
2016	N/R	89	$2,735
2017	N/R	24	$4,125
2018	N/R	N/R	N/R
2019	N/R	14	$1,210
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	35	$2,490
2023	N/R	13	$1,418
2024	N/R	38	$3,384

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36415	Insertion of needle into vein for collection of blood sample	815	2,449	$9
80076	Liver function blood test panel	742	1,682	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	812	2,421	$8
82565	Blood creatinine level	744	1,688	$5
84520	Urea nitrogen level to assess kidney function, quantitative	746	1,691	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Inlyta	Axitinib	14	480	$279,217
Imatinib Mesylate	Imatinib Mesylate	20	586	$103,107
Zarxio	Filgrastim-Sndz	15	342	$51,861
Eliquis	Apixaban	58	2,160	$40,912
Xarelto	Rivaroxaban	49	1,770	$32,463

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$1,780
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	12	$1,088
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$516

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$305	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vijay Paudel, MD?

Tedicare shows public-source Medicare data for Vijay Paudel, MD (NPI 1972596484), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vijay Paudel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vijay Paudel, MD?

Vijay Paudel, MD is linked to COASTAL CANCER CENTER LLC (billing NPI 1881614170) in the available physician profile data.

Does Vijay Paudel, MD have Open Payments data?

Vijay Paudel, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.